Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin

Acta Neurobiologiae Experimentalis

Volumn 64, Issue 4, 2004, Pages 481-489

  Grieb, Paweł ^a   Kryczka, Tomasz ^a   Fiedorowicz, Michał ^a   Frontczak Baniewicz, Małgorzata ^a   Walski, Michał ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Alzheimer's disease; Golgi apparatus; Streptozotocin

Indexed keywords

AMYLOID BETA PROTEIN; CELL PROTEIN; INSULIN RECEPTOR; STREPTOZOCIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN VENTRICLE; CELL ULTRASTRUCTURE; DESENSITIZATION; DRUG EFFECT; ENERGY METABOLISM; GLUCOSE TRANSPORT; GOLGI COMPLEX; MORPHOMETRICS; NONHUMAN; PROTEIN PROCESSING; PROTEIN SECRETION; RAT; SAMPLING; STREPTOZOCIN DIABETES;

ANIMALS; CEREBRAL CORTEX; GOLGI APPARATUS; INJECTIONS, INTRAVENTRICULAR; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 9644260712     PISSN: 00651400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Biessels GJ, Braun KP, de Graaf RA, van Eijsden P, Gispen WH, Nicolay K (2001) Cerebral metabolism in streptozotocin-diabetic rats: an in vivo magnetic resonance spectroscopy study. Diabetologia 44: 346-353.
2. Brunk UT, Terman A (2002) Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 33: 611-619.
3. Dal Canto MC (1996) The Golgi apparatus and the pathogenesis of Alzheimer's disease. Am J Pathol 148: 355-360.
4. del Valle M, Robledo Y, Sandoval IV (1999) Membrane flow through the Golgi apparatus: specific disassembly of the cis-Golgi network by ATP depletion. J Cell Sci 112: 4017-4029.
5. Duelli R, Schrock H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12: 737-743.
6. Glick BS (2000) Organization of the Golgi apparatus. Curr Opin Cell Biol 12: 450-456.
7. Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, Sisodia SS, Greengard P, Xu H (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci U S A 96: 742-747.
8. Grieb P, Gordon-Krajcer W, Frontczak-Baniewicz M, Walski M, Ryba MS, Kryczka T, Fiedorowicz M, Kulinowski P, Sułek Z, Majcher K, Jasiński A (2004) 2-Deoxyglucose induces β-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in the rat cerebral cortex. Acta Neurobiol Exp (Wars) 64:491-502.
9. Hardy J, Higgins GA (1992) Alzheimer's disease: The amyloid hypothesis. Science 256: 1124-1125.
10. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
11. Hoyer S (2002a) The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 109: 341-360.
12. Hoyer S (2002b) The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neural Transm 109: 991-1002.
13. Hoyer S, Lannert H (1999) Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann N Y Acad Sci 893: 301-303.
14. Hoyer S, Lee SK, Loffler T, Schliebs R (2000) Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease? Ann N Y Acad Sci 920:256-528.
15. Huse JT, Liu K, Pijak DS, Carlin D, Lee VM, Doms RW (2002) Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. J Biol Chem 277: 16278-16284.
16. Ito M, Kondo Y, Nakatani A, Naruse A (1999) New model of progressive non-insulin-dependent diabetes mellitus in mice induced by streptozotocin. Biol Pharm Bull 22: 988-989.
17. Kadowaki T, Kasaga M, Akamuma Y, Ezaki O, Takaku F (1984) Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin diabetic rats. J Biol Chem 259: 14208-14216.
18. Kordowiak AM (1986) Cytoprotective effect of 16,16′-dimethyl prostaglandin E2 (dm PGE2) on streptozotocin-induced biochemical alterations of Golgi-rich membrane fraction in comparison with morphology of rat liver Golgi apparatus in situ. Pathol Res Pract 181: 397-401.
19. Kwon NS, Lee SH, Choi CS, Kho T, Lee HS (1994) Nitric oxide generation from streptozotocin. FASEB J 8: 529-533.
20. Ladinsky MS, Wu CC, McIntosh S, McIntosh JR, Howell KE (2002) Structure of the Golgi and distribution of reporter molecules at 20 degrees C reveals the complexity of the exit compartments. Mol Biol Cell 13: 2810-2825.
21. Lewis C, Barbiers AR (1960) Streptozotocin, a new antibiotic. In vitro and in vivo evaluation. Antibiot Ann 22: 247-254.
22. Lucassen PJ, Salehi A, Pool CW, Gonatas NK, Swaab DF (1994) Activation of vasopressin neurons in aging and Alzheimer's disease. J Neuroendocrinol 6: 673-679.
23. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47: 224-229.
24. Mattson MP (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77: 1081-132.
25. Meier-Ruge W, Bertoni-Freddari C (1996) The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease. Rev Neurosci 7: 1-19.
26. Meyerovitch J, Backer JM, Kahn CR (1989) Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats. J Clin Invest 84: 976-983.
27. Muller D, Nitsch RM, Wurtman RJ, Hoyer S (1998) Streptozotocin increases free fatty acids and decreases phospholipids in rat brain. J Neural Transm 105: 1271-1281.
28. Pavelka M, Ellinger A (1991) Cytochemical characteristics of the Golgi apparatus. J Electron Microsc Tech 17: 35-50.
29. Pezzino V, Costantino A, Russo P, Gullo D, Papa V (1996) Insulin receptor content in tissues of normal and diabetic rats measured by radioimmunoassay. J Endocrinol Invest 19: 593-597.
30. Prickaerts J, Fahrig T, Blokland A (1999) Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav Brain Res 102: 73-88.
31. Rakieten N, Rakieten ML, Nadkarni MV (1963) Studies on the diabetogenic action of streptozotocin. Cancer Chemother Rep 29: 91-98.
32. Salehi A, Swaab DF (1999) Diminished neuronal metabolic activity in Alzheimer's disease. Review article. J Neural Transm 106: 955-986.
33. Salehi A, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF (1994) Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience 59: 871-880.
34. Salehi A, Ravid R, Gonatas NK, Swaab DF (1995a) Decreased activity of hippocampal neurons in Alzheimer's disease is not related to the presence of neurofibrillary tangles. J Neuropathol Exp Neurol 54: 704-709.
35. Salehi A, Heyn S, Gonatas NK, Swaab DF (1995b) Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus. Neurosci Lett 193: 29-32.
36. Salehi A, Van de Nes JA, Hofman MA, Gonatas NK, Swaab DF (1995c) Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Brain Res 678: 28-39
37. Salehi A, Pool CW, Mulder M, Ravid R, Gonatas NK, Swaab DF (1998) Activity of hippocampal CA1 neurons in Alzheimer's disease is not affected by the presence of adjacent neuritic plaques. J Alzheimers Dis 1: 107-118.
38. Sarnecka-Keller M, Kaczmarski F, Kordowiak A (1980) Morphology of the Golgi apparatus in streptozotocin-diabetic rat liver. Pathol Res Pract 168: 126-133.
39. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-776.
40. Sharma M, Gupta YK (2001a) Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci 68: 1021-1029.
41. Sharma M, Gupta YK (2001b) Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol Biochem Behav 70: 325-3231.
42. Sharma M, Gupta YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71: 2489-2898.
43. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero R, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760.
44. Stieber A, Mourelatos Z, Gonatas NK (1996) In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am J Pathol 148: 415-426.
45. Veerendra Kumar MH, Gupta YK (2003) Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol 30: 336-342.
46. White FR (1963) Streptozotocin. Cancer Chemother Rep 30: 49-53.
47. Wilson GL, Leiter EH (1990) Streptozotocin interactions with pancreatic β cells and the induction of insulin-dependent diabetes. Curr Top Microb Immunol 156: 27-33.